Company / SG&A per Share
Evolent Health, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.73
FY2025
5-year range
$2.66 / $4.16
FY2021-FY2025
Trend
-2.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $2.66 in FY2021 to $69.44 in FY2016.
Based on SEC 10-K filings.
2.73 in FY2025 with a 5-year CAGR of +0.1%.
Improved from $4.16 to $2.73 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- +0.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 2.7% year-over-year.
- Peak sg&a per share was recorded in FY2016.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.73 | -2.7% |
| FY2024 | $2.81 | -32.5% |
| FY2023 | $4.16 | +31.2% |
| FY2022 | $3.17 | +19.0% |
| FY2021 | $2.66 | -2.0% |
| FY2020 | $2.72 | -26.0% |
| FY2019 | $3.67 | -29.7% |
| FY2018 | $5.23 | +17.3% |
| FY2017 | $4.46 | -93.6% |
| FY2016 | $69.44 | +175.6% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026